An updated surgical approach for a neurostimulation device to treat OSA reduces surgery time and pain for patients.
Among patients with obstructive sleep apnea, women and those who previously used oral appliances are most likely to be denied insurance coverage of upper airway stimulation therapy, a new study finds.
Obstructive sleep apnea is linked not just with heart disease, but with poor quality of life, drowsy driving, depression, metabolic disease and cognitive impairment.
In the U.S., 82% of men and 93% of women with obstructive sleep apnea are undiagnosed. This overview summarizes symptoms, risk factors and comorbidities, and outlines screening tools and diagnostic criteria.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
One of the first clinic-based studies comparing positive airway pressure and upper airway stimulation finds each to have advantages in differing outcomes, laying the groundwork for future studies.
The Inspire® Upper Airway Stimulation system is a successful intervention for many patients with obstructive sleep apnea, who are not candidates for continuous positive airway pressure. Two recent studies showed new insights about how to improve outcomes with the device by making post-operative awake endoscopy adjustments and a comparative review of HNS outcomes versus traditional airway reconstruction.
A long-term study has confirmed the durability of benefits and safety of a newly FDA-approved drug to treat excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea.
The international ADHERE registry of real-world use of hypoglossal nerve stimulation also showed a nonsignificant trend toward better outcomes in women than in men.
Alan Kominsky, MD, Section Head of Surgical Sleep and Snoring in Cleveland Clinic’s Head & Neck Institute, says hypoglossal nerve stimulation is changing the surgical paradigm for OSA. Here’s why.
A new study shows adults over 60 with sleep apnea achieve improvements in sleepiness, fatigue, depression and quality of life comparable to those in their younger counterparts.